注册Cytiva中文官网

ULTA™ Prime CG normal flow filter capsules

Filtration capsules for upstream bioburden reduction, compatible with a wide range of chemicals.

Filtration capsules for upstream bioburden reduction, compatible with a wide range of chemicals.
  • Can be repeatedly steam sterilized in situ, autoclaved at up to 130°C, or sanitized with hot water at up to 90°C.
  • Materials conform to the relevant biological safety requirements of 21 CFR Part 177 current USP Plastics Class VI – 121°C and ISO10993 equivalents.
  • Meet current USP quality standards for oxidizable substances.
  • Aqueous extracts from ULTA Prime CG contain < 0.125 EU/mL when tested in accordance with the standard (LAL) test for endotoxins.
  • Effluent quality conforms to the requirements of USP28<643> (TOC) and USP28<645> (conductivity).
  • Full pharmaceutical validation guide available on request.

Designed for bioburden control

ULTA Prime CG filter capsules are specifically designed for bioburden control and particle retention in a variety of pH ranges and feed streams. The pleated polyethersulfone (PES) membrane combined with thermal-bonded construction ensures low extractables and quick flushup devices.

All products are 100% integrity tested before release and are shipped with a certificate of quality.

ÄKTA process CFG售后培训

立即学习

ÄKTA process CFG售后培训

观看学习

新型外泌体生产制备方案探究

立即学习

新型外泌体生产制备方案探究

观看学习

重组胶原蛋白CMC平台搭建

立即学习

重组胶原蛋白CMC平台搭建

观看学习

胶原蛋白的工艺开发思路和方案

立即学习

胶原蛋白的工艺开发思路和方案

观看学习

GLP-1RA下游工艺新技术的发展和应用

立即学习

GLP-1RA下游工艺新技术的发展和应用

观看学习

Biacore助力中医药现代化研究

立即学习

Biacore助力中医药现代化研究

观看学习

ÄKTA层析新技术提质外源表达蛋白的纯化制备

立即学习

ÄKTA层析新技术提质外源表达蛋白的纯化制备

观看学习

寡核酸药物下游工艺开发策略

立即学习

寡核酸药物下游工艺开发策略

观看学习